Wang, Ling <br/><br/>
Bu-Shen-Ning-Xin decoction: inhibition of osteoclastogenesis by abrogation of the RANKL-induced NFATc1 and NF-κB signaling pathways via selective estrogen receptor α.  [electronic resource] 

 -  Drug design, development and therapy  2015 
 - 3755-66 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1177-8881 
<br/><br/><label>Standard No.: </label>10.2147/DDDT.S88512  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Bone Resorption--drug therapy<br/>Cell Differentiation--drug effects<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Drugs, Chinese Herbal--administration & dosage<br/>Estradiol--blood<br/>Estrogen Receptor alpha--metabolism<br/>Female<br/>Humans<br/>Immunoenzyme Techniques<br/>Mice<br/>Mice, Inbred BALB C<br/>NF-kappa B--metabolism<br/>NFATC Transcription Factors--metabolism<br/>Osteoclasts--drug effects<br/>Osteoporosis, Postmenopausal--drug therapy<br/>Ovariectomy<br/>Signal Transduction--drug effects